Abstract LB181: First disclosure of XRD-0394, a novel dual ATM/DNA-PK inhibitor, that potently radiosensitizes and potentiates PARP and topoisomerase inhibitorsTona M. Gilmer, Michael B. Kastan, Yaode Wang et al.|Cancer Research|2024Cited by 4